Immune Thrombocytopenia in a Child with T Cell Lymphoblastic Lymphoma.
We describe the case of a 13-year-old boy who presented with persistent thrombocytopenia during maintenance chemotherapy with mercaptopurine and methotrexate for T cell lymphoblastic lymphoma. He was diagnosed with immune thrombocytopenia (ITP) after thorough investigations for the relapse of lymphoma and was successfully treated with immunoglobulin and steroids. ITP is known to be associated with chronic lymphocytic leukemia, Hodgkin lymphoma, and various types of non-Hodgkin lymphoma but rarely with T cell non-Hodgkin lymphoma or in children. Diagnosis of ITP with lymphoma is challenging due to the many factors affecting platelet counts, and ITP often complicates the diagnosis or treatment course of lymphoma. The underlying mechanism of ITP with NHL is still unclear. Drug-induced immunomodulation with a reduction of regulatory T cells might have contributed to the development of ITP in our case.
Department of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Kayo
0000-0003-2226-7614
K
Tokeji
Department of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Sachi
0000-0003-0119-1796
S
Sakaguchi
Department of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Tomoko
T
Kurimoto
Department of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Junya
J
Fujimura
Department of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Toshiaki
T
Shimizu
Haematologica. 2008 Mar;93(3):447-50
18287133
Ann Oncol. 2014 Oct;25(10):2025-30
25081899
Br J Haematol. 1998 May;101(2):242-4
9609516
Eur J Haematol. 2007 Feb;78(2):139-43
17328716
Pathol Res Pract. 2010 Apr 15;206(4):270-5
19442454